http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105820352-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2305-08 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-28 |
filingDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105820352-B |
titleOfInvention | A kind of preparation method of electropositive chitin nanofiber hydrogels and aeroge |
abstract | The invention discloses the preparation methods of a kind of electropositive chitin nanofiber hydrogels and aeroge, including 1)It takes chitin raw material to be pre-processed, obtains chitin slurry;2)Chitin slurry obtains part deacetylation chitin through room temperature or high temperature alkali process;3)Electropositive chitin nanofiber dispersion liquid is prepared through mechanical treatment in slightly acidic water solution in part deacetylation chitin;4)The electropositive chitin nanofiber hydrogels of physical crosslinking are prepared through alkaline coagulating bath processing for electropositive chitin nanofiber dispersion liquid;5)Electropositive chitin nanofiber aeroge is prepared through drying and dehydrating in electropositive chitin nanofiber hydrogels.This method is simple and operability is strong, prepared by realization hydrogel that can be inexpensive;Prepared chitin nanofiber hydrogels, aerogel material have form good, and concentration is low, and intensity is high, bio-compatible and nontoxic advantage, has a good application prospect in terms of biological medicine. |
priorityDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.